Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,276.7 Cr 3.8% 7.5% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹110,515.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -0.8% -0.5% -9.3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

3.8%

7.5%

13.6%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses